Anxo Pharmaceutical Co., Ltd.(TW:6677)
NT$20.80-0.75 (-1.42%)
TW:6677
Anxo Pharmaceutical Co., Ltd. Revenue
NT$20.80
At close:-0.75 (-1.42%)
Anxo Pharmaceutical Co., Ltd. (6677) Revenue
Anxo Pharmaceutical Co., Ltd. Revenue
Anxo Pharmaceutical Co., Ltd. had a revenue of 438.39M in the quarter ending Jun 30, 2026, with -0.47%. This bring the company's revenue in the last twelve months to 878.88M, Increased 4.22%. In the fiscal year ending Dec 31, 2025, Anxo Pharmaceutical Co., Ltd. had annual revenue of 843.26M with -5.81% growth.
- Revenue (ttm)
- 878.88M
- Revenue Growth
- -0.49%
- P/S Ratio
- 1.38
- Revenue/Employee
- TWD 56,217,533
- Employees
- 15
- Market Cap
- TWD 1.17B
Revenue Chart
Anxo Pharmaceutical Co., Ltd. Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 843.26M | -52.06M | -5.81% |
| Dec 31, 2024 | 895.32M | -44.62M | -4.75% |
| Dec 31, 2023 | 939.94M | 73.67M | 8.50% |
| Dec 31, 2022 | 866.27M | 42.17M | 5.12% |
| Dec 31, 2021 | 824.10M | -42.01M | -4.85% |
| Dec 31, 2020 | 866.11M | -11.82M | -1.35% |
| Dec 31, 2019 | 877.93M | 27.98M | 3.29% |
| Dec 31, 2018 | 849.95M | 145.19M | 20.60% |
| Dec 31, 2017 | 704.76M | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.